Finally, we demonstrate that SLED-based AAV constructs perform as efficiently as state-of-the-art minipromoter vectors for functional rescue of photoreceptor dystrophies, and also show that SLED can be used to selectively target SF3B1 mutant cancer cells for oncolytic therapy. Here, SF3B1 is linked to cancer.